Max Robotics — Global Service Robot Directory + US Certification

About

Hiroshi Nagata is a leading figure in rehabilitation robotics and minimally invasive surgical oncology, with a career defined by translating cutting-edge technology into tangible clinical improvements. His primary research focuses on the application of robotic exoskeletons for neurorehabilitation, particularly the Hybrid Assistive Limb (HAL), and the comparative effectiveness of robotic versus laparoscopic surgery for colorectal cancer. Nagata’s most impactful work, a 2016 pilot study on HAL gait training for subacute stroke patients (41 citations), demonstrated the safety and efficacy of this wearable robot in enhancing functional mobility and walking ability in individuals with hemiparesis. He further validated these findings through multi-single-case studies, solidifying HAL’s role in stroke rehabilitation. In surgical oncology, his 2024 propensity score-matched analysis (9 citations) provides crucial short- and long-term outcome data comparing robotic and laparoscopic approaches for rectal cancer, informing evidence-based surgical decision-making. Nagata’s contributions bridge the gap between advanced robotics and patient-centered care, establishing him as a key innovator in both restoring movement and refining surgical precision.